Public, NASDAQ:DARA
NASDAQ Capital Market
DARA BIOSCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhib
Date: Wed, 18 Jan 2012 14:06:00 GMT
Tags:
DARA BioSciences Signs Definitive Agreement to Raise $1.7 Million in Registered Direct Offering
Date: Wed, 18 Jan 2012 13:45:00 GMT
Tags:
[GlobeNewswire] - RALEIGH, N.C. -- DARA BioSciences, Inc. today announced that it has entered into a definitive agreement with one institutional investor providing for the sale of $1.7 million of shares of Series B convertible ...
Nasdaq stocks posting largest volume increases
Date: Tue, 17 Jan 2012 23:03:54 GMT
Tags:
DARA BIOSCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisition or D
Date: Tue, 17 Jan 2012 14:03:01 GMT
Tags:
DARA BioSciences Announces Acquisition of U.S. Marketing Rights to Soltamox(TM), an FDA Approved Liquid Formulation of Tamoxifen for the Treatment of Breast Cancer
Date: Tue, 17 Jan 2012 13:45:00 GMT
Tags:
[GlobeNewswire] - Soltamox(TM) and Other Product Opportunities Enabled Through Acquisition of Oncogenerix, a Private South Carolina-Based Oncology Company